Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H12O6 |
Molecular Weight | 300.2629 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1O)C2=CC(=O)C3=C(O2)C=C(O)C=C3O
InChI
InChIKey=MBNGWHIJMBWFHU-UHFFFAOYSA-N
InChI=1S/C16H12O6/c1-21-13-3-2-8(4-10(13)18)14-7-12(20)16-11(19)5-9(17)6-15(16)22-14/h2-7,17-19H,1H3
Diosmetin is the aglycone of the flavonoid glycoside diosmin, which occurs naturally in citrus fruits. Diosmetin is found in the legume Acacia farnesiana Wild and Olea europaea L. leaves. Diosmin is hydrolyzed to its aglycone diosmetin by intestinal microflora enzymes before its absorption into the body. Pharmacologically, diosmetin is reported to exhibit anticancer, antimicrobial, antioxidant, oestrogenic and anti-inflammatory activities. Diosmetin increased inhibitory GSK-3beta phosphorylation, while selectively reducing gamma-secretase activity, Abetta generation, tau hyperphosphorylation and pro-inflammatory activation of microglia in vitro, without altering Notch processing. Therefore, diosmetin could be considered as potential candidate for novel anti- Alzheimer's disease therapy. Diosmetin is ER-beta agonist and potential novel drug for the acute myeloid leukemia treatment.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2231 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20696580 |
140.0 nM [IC50] | ||
Target ID: CHEMBL3356 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20696580 |
2.4 µM [IC50] | ||
Target ID: CHEMBL4878 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20696580 |
29.0 nM [IC50] | ||
Target ID: CHEMBL242 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28835383 |
|||
Target ID: map04064 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28101238 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Preventing | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Resistance of MCF-7 cells to dimethylbenz(a)anthracene-induced apoptosis is due to reduced CYP1A1 expression. | 2002 Aug |
|
A benzoquinone and flavonoids from Cyperus alopecuroides. | 2002 Jun |
|
Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids-structural requirements. | 2002 May |
|
Structural requirements of flavonoids for inhibition of antigen-Induced degranulation, TNF-alpha and IL-4 production from RBL-2H3 cells. | 2002 Oct |
|
DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells. | 2003 Feb 24 |
|
Degradation of flavonoid aglycones by rabbit, rat and human fecal flora. | 2003 May |
|
Structural requirements of flavonoids for nitric oxide production inhibitory activity and mechanism of action. | 2003 May 1 |
|
The beta-D-glucoside and sodium-dependent glucose transporter 1 (SGLT1)-inhibitor phloridzin is transported by both SGLT1 and multidrug resistance-associated proteins 1/2. | 2003 Nov |
|
Free radical scavenging abilities of flavonoids as mechanism of protection against mutagenicity induced by tert-butyl hydroperoxide or cumene hydroperoxide in Salmonella typhimurium TA102. | 2003 Sep 9 |
|
A validated HPLC determination of the flavone aglycone diosmetin in human plasma. | 2004 Dec |
|
Metabolism of apigenin by rat liver phase I and phase ii enzymes and by isolated perfused rat liver. | 2004 Jan |
|
Effect of the rootstock and interstock grafted in lemon tree (Citrus limon (L.) Burm.) on the flavonoid content of lemon juice. | 2004 Jan 28 |
|
Antitubercular constituents of Valeriana laxiflora. | 2004 Jun |
|
Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships. | 2004 Nov 15 |
|
[Investigation of the hepatoprotector action of natural flavonoids]. | 2004 Nov-Dec |
|
Flavonoid glycosides inhibit oral cancer cell proliferation--role of cellular uptake and hydrolysis to the aglycones. | 2005 Aug |
|
Analysis and quantification of flavonoidic compounds from Portuguese olive (Olea europaea L.) leaf cultivars. | 2005 Feb |
|
Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. | 2005 Feb 15 |
|
In vitro antioxidant activity of some Teucrium species (Lamiaceae). | 2005 Jun |
|
Determination of active components in rosemary by capillary electrophoresis with electrochemical detection. | 2005 Sep 15 |
|
The efflux of flavonoids morin, isorhamnetin-3-O-rutinoside and diosmetin-7-O-beta-D-xylopyranosyl-(1-6) -beta-D-glucopyranoside in the human intestinal cell line caco-2. | 2006 Aug |
|
Polar constituents from the aerial parts of Origanum vulgare L. Ssp. hirtum growing wild in Greece. | 2006 Jul 26 |
|
Flavonoid glycosides in bergamot juice (Citrus bergamia Risso). | 2006 May 31 |
|
Anti-proliferative and antioxidant constituents from Tecoma stans. | 2006 Nov-Dec |
|
Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. | 2006 Oct 16 |
|
Raddeanalin, a new flavonoid glycoside from the leaves of Salix raddeana Laksh. | 2007 Apr-Aug |
|
Complete assignments of NMR data of 13 hydroxymethoxyflavones. | 2007 Dec |
|
A new flavone glycoside from the fruits of Luffa cylindrica. | 2007 Dec |
|
Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo. | 2007 Feb |
|
Pensteminoside, an unusual catalpol-type iridoid from Penstemon gentianoides HBK (Plantaginaceae). | 2007 Jul |
|
Plant-derived polyphenols attenuate lipopolysaccharide-induced nitric oxide and tumour necrosis factor production in murine microglia and macrophages. | 2008 Apr |
|
Prediction of intestinal absorption and metabolism of pharmacologically active flavones and flavanones. | 2008 Apr 1 |
|
Effect of flavonoids on rat splenocytes, a structure-activity relationship study. | 2008 Aug 15 |
|
Different flavonoids present in the micronized purified flavonoid fraction (Daflon 500 mg) contribute to its anti-hyperpermeability effect in the hamster cheek pouch microcirculation. | 2008 Feb |
|
New features on the fragmentation and differentiation of C-glycosidic flavone isomers by positive electrospray ionization and triple quadrupole mass spectrometry. | 2008 Jun |
|
Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes. | 2008 Mar 15 |
|
Acasiane A and B and farnesirane A and B, diterpene derivatives from the roots of Acacia farnesiana. | 2009 Feb |
|
Aurintricarboxylic acid inhibits influenza virus neuraminidase. | 2009 Feb |
|
Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. | 2009 Jun 16 |
|
[Chemical constituents of Galium verum]. | 2009 Nov |
|
Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitro. | 2010 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28835383
Mice: 50mg /kg/every other day for 6 weeks
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19424633
Diosmetin caused G1 arrest at 10 microM in MDA-MB 468 cells after 48-h treatment whereas this effect was not observed in MCF-10A cells.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
4156 (Number of products:7)
Created by
admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB35834
Created by
admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
|
PRIMARY | |||
|
8101
Created by
admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
|
PRIMARY | |||
|
DIOSMETIN
Created by
admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
|
PRIMARY | |||
|
DTXSID80199966
Created by
admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
|
PRIMARY | |||
|
TWZ37241OT
Created by
admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
|
PRIMARY | |||
|
100000128590
Created by
admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
|
PRIMARY | |||
|
5281612
Created by
admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
|
PRIMARY | |||
|
4630
Created by
admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
|
PRIMARY | |||
|
1314347
Created by
admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
|
PRIMARY | RxNorm | ||
|
520-34-3
Created by
admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
|
PRIMARY | |||
|
TWZ37241OT
Created by
admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
|
PRIMARY | |||
|
4601
Created by
admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
|
PRIMARY | |||
|
208-291-8
Created by
admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
|
PRIMARY | |||
|
m4594
Created by
admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
|
PRIMARY | Merck Index | ||
|
C039602
Created by
admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
|
PRIMARY | |||
|
DB11259
Created by
admin on Fri Dec 15 17:33:37 GMT 2023 , Edited by admin on Fri Dec 15 17:33:37 GMT 2023
|
PRIMARY |
ACTIVE MOIETY